tradingkey.logo

cbdMD Inc

YCBD
1.490USD
-0.440-22.80%
收盤 12/19, 16:00美東報價延遲15分鐘
13.27M總市值
虧損本益比TTM

cbdMD Inc

1.490
-0.440-22.80%

關於 cbdMD Inc 公司

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

cbdMD Inc簡介

公司代碼YCBD
公司名稱cbdMD Inc
上市日期Nov 17, 2017
CEOKennedy (T. Ronan)
員工數量42
證券類型Ordinary Share
年結日Nov 17
公司地址8845 Red Oak Blvd
城市CHARLOTTE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編28217-5593
電話17044453060
網址https://www.cbdmd.com/
公司代碼YCBD
上市日期Nov 17, 2017
CEOKennedy (T. Ronan)

cbdMD Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
2.23K
+239.63%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
2.12K
+286.34%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
2.23K
+239.63%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
2.12K
+286.34%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
業務USD
名稱
營收
佔比
E-commerce sales
3.58M
77.70%
Wholesale sales
1.03M
22.30%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
E-commerce sales
3.58M
77.70%
Wholesale sales
1.03M
22.30%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Crc Investment Fund LP
13.10%
Kennedy (Thomas Ronan)
4.82%
CSS, LLC
1.51%
Chapin Davis Asset Management
1.29%
Porter (Jeffrey H)
0.78%
其他
78.50%
持股股東
持股股東
佔比
Crc Investment Fund LP
13.10%
Kennedy (Thomas Ronan)
4.82%
CSS, LLC
1.51%
Chapin Davis Asset Management
1.29%
Porter (Jeffrey H)
0.78%
其他
78.50%
股東類型
持股股東
佔比
Corporation
13.84%
Individual Investor
7.24%
Investment Advisor
4.75%
Investment Advisor/Hedge Fund
0.13%
其他
74.03%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
51
502.25K
5.64%
+188.29K
2025Q2
61
1.71M
19.14%
+1.55M
2025Q1
80
154.62K
3.22%
-19.13K
2024Q4
76
811.68K
23.02%
+42.15K
2024Q3
80
869.63K
30.51%
+134.84K
2024Q2
85
734.40K
27.03%
-50.91K
2024Q1
91
757.62K
28.39%
-18.50K
2023Q4
95
764.16K
29.72%
+83.63K
2023Q3
108
684.81K
27.23%
+10.72K
2023Q2
117
634.68K
40.66%
-58.78K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Crc Investment Fund LP
1.23M
13.84%
+1.23M
--
May 06, 2025
Kennedy (Thomas Ronan)
9.31K
0.1%
+8.48K
+1023.40%
May 06, 2025
CSS, LLC
142.62K
1.6%
+142.62K
--
Jun 30, 2025
Chapin Davis Asset Management
118.63K
1.33%
+118.63K
--
Jun 30, 2025
Porter (Jeffrey H)
73.26K
0.82%
+73.26K
--
May 16, 2025
Alesco Advisors LLC
68.51K
0.77%
+68.51K
--
Jun 30, 2025
Coffman (Raymond Scott)
48.46K
0.54%
--
--
Feb 21, 2025
Lambeth (Marianne)
46.70K
0.52%
--
--
Feb 21, 2025
Commonwealth Financial Network
16.25K
0.18%
+16.25K
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Cambria Cannabis ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Amplify Seymour Cannabis ETF
0%
Cambria Cannabis ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
Amplify Seymour Cannabis ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
公告日期
類型
比率
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1

常見問題

cbdMD Inc的前五大股東是誰?

cbdMD Inc的前五大股東如下:
Crc Investment Fund LP
持有股份:1.23M
佔總股份比例:13.84%。
Kennedy (Thomas Ronan)
持有股份:9.31K
佔總股份比例:0.10%。
CSS, LLC
持有股份:142.62K
佔總股份比例:1.60%。
Chapin Davis Asset Management
持有股份:118.63K
佔總股份比例:1.33%。
Porter (Jeffrey H)
持有股份:73.26K
佔總股份比例:0.82%。

cbdMD Inc的前三大股東類型是什麼?

cbdMD Inc 的前三大股東類型分別是:
Crc Investment Fund LP
Kennedy (Thomas Ronan)
CSS, LLC

有多少機構持有cbdMD Inc(YCBD)的股份?

截至2025Q3,共有51家機構持有cbdMD Inc的股份,合計持有的股份價值約為502.25K,占公司總股份的5.64% 。與2025Q2相比,機構持股有所增加,增幅為-13.51%。

哪個業務部門對cbdMD Inc的收入貢獻最大?

在FY2025Q3,E-commerce sales業務部門對cbdMD Inc的收入貢獻最大,創收3.58M,占總收入的77.70% 。
KeyAI